Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 15;28(3):030703.
doi: 10.11613/BM.2018.030713.

Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development

Milica Stevanovic  1 , Jelena Vekic  1 , Natasa Bogavac-Stanojevic  1 , Jelena Janac  1 , Zeljka Stjepanovic  2 , Dejan Zeljkovic  3 , Bratislav Trifunovic  3   4 , Vesna Spasojevic-Kalimanovska  1 , Aleksandra Zeljkovic  1
Affiliations

Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development

Milica Stevanovic et al. Biochem Med (Zagreb). .

Abstract

Introduction: Dyslipidaemia contributes to the occurrence of colorectal cancer (CRC). We hypothesized that qualitative changes of lipoproteins are associated with the risk for CRC development. This study analyses low-density lipoprotein (LDL) and high-density lipoprotein (HDL) diameters, as well as distribution of LDL and HDL subclasses in patients with CRC, with an aim to determine whether advanced lipid testing might be useful in predicting the risk for the onset of this malignancy.

Materials and methods: This case-control study included 84 patients with newly diagnosed CRC and 92 controls. Gradient gel electrophoresis was applied for separation of lipoprotein subclasses and for LDL and HDL diameters determination. Lipid parameters were measured using routine enzymatic methods.

Results: Total cholesterol, HDL and LDL-cholesterol were significantly lower in CRC patients compared to controls (4.47 mmol/L vs. 5.63 mmol/L; 0.99 mmol/L vs. 1.27 mmol/L; 2.90 mmol/L vs. 3.66 mmol/L; P < 0.001, respectively). Patients had significantly smaller LDL (25.14 nm vs. 26.92 nm; P < 0.001) and HDL diameters (8.76 nm vs. 10.17 nm; P < 0.001) and greater proportion of small, dense LDL particles (54.0% vs. 52.9%; P = 0.044) than controls. Decreased LDL and HDL diameters were independent predictors of CRC (OR = 0.5, P = 0.001 and OR = 0.5, P = 0.008, respectively), and alongside with age and HDL-cholesterol concentrations formed the optimal cost-effective model, providing adequate discriminative abilities for CRC (AUC = 0.89) and correct patients classification (81%).

Conclusions: Patients with CRC have decreased LDL and HDL diameters and increased proportion of smaller particles. LDL and HDL diameters determination could be useful in assessing the risk for CRC development.

Keywords: colorectal cancer; cost-effectiveness; lipoprotein size; lipoprotein subclasses; risk prediction.

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest: None declared.

Figures

Figure 1
Figure 1
The flowchart illustrating the study cohort and approach
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev. 2016;25:16–27. 10.1158/1055-9965.EPI-15-0578 - DOI - PubMed
    1. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology. 2010;138:2029–43.e10. 10.1053/j.gastro.2010.01.057 - DOI - PMC - PubMed
    1. Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279:2610–23. 10.1111/j.1742-4658.2012.08644.x - DOI - PubMed
    1. Agnoli C, Grioni S, Sieri S, Sacerdote C, Vineis P, Tumino R, et al. Colorectal cancer risk and dyslipidemia: a case–cohort study nested in an Italian multicentre cohort. Cancer Epidemiol. 2014;38:144–51. 10.1016/j.canep.2014.02.002 - DOI - PubMed
    1. Munir R, Usman H, Hasnain S, Smans K, Kalbacher H, Zaidi N. Atypical plasma lipid profile in cancer patients: cause or consequence? Biochimie. 2014;102:9–18. 10.1016/j.biochi.2014.03.010 - DOI - PubMed